ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
University of Leeds at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
University of Leeds takes part in 5 sessions at ESMO 2026 in Madrid. Its work focuses on gastrointestinal cancers and biomarkers, including colorectal and pancreatic cancer. It examines whether omega-3 fatty acid treatment after surgery for colorectal cancer that has spread to the liver affects outcomes.
| Organization | ESMO 2026 Attendance |
|---|---|
University of Leeds Leeds, United Kingdom | |
Public research university in Leeds, United Kingdom, with a school of medicine. | Abstract Sat Oct 24 09:00–09:05 Abstract Sun Oct 25 10:25–10:35 Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Complete absence of race and ethnicity data in the largest PDAC genomic dataset prevents equity-relevant validation of emerging allele dosage biomarkers: A data governance audit Gastrointestinal cancersBiomarkers & precision oncology Poster Sun Oct 25 12:00–12:45 |
Find decision makers at University of Leeds
Tell us what you sell and we’ll find the people at University of Leeds most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction